02.10.2012 • News

Azelis Announces Sale of its Composites Business

On October 1st, Azelis announced the sale of its international Composites business to Velox who has acquired this business in its entirety. As a result, Velox will take over and manage the Composites business and its employees, effective October 1st, 2012.

As part of the company's natural progression and clear focus on value added growth within specialities, a strategic review was undertaken by the Azelis board and the Composites market was judged to be sub-critical to the company's plans for future development. Within the markets it serves, industrial chemicals, coatings, rubber & plastic and Life Sciences have been identified as primary value added growth areas within Europe. Further expansion within Asia Pacific is also another key pillar using a speciality chemicals business model.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read